Magle Biopolymers A/S
CVR 14893695 · Public limited company (A/S) · Active · Low risk
Magle Biopolymers A/S is a Public limited company (A/S), founded on , based in Køge. The company is registered in the industry fremstilling af plast i ubearbejdet form. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 83.2m and a net result of DKK -65.7m.
Bankruptcy risk for Magle Biopolymers A/S
0.0 × the average (1.41%) · higher risk than 18% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 14893695
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (35 years)
- Address
- Københavnsvej 140
4600 Køge - Municipality
- Køge
- Industry
- Fremstilling af plast i ubearbejdet form (201600)
Bankruptcies in the industry: Fremstilling af friske bageriprodukter - Share capital
- DKK 3.5m
- Employees
- 75 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 29.0% |
| Current ratio | 46% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 7 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 23.9m | DKK 42.0m | DKK 61.0m |
| Net profit | DKK -65.7m | DKK -21.3m | DKK -7.6m |
| Equity | DKK 83.2m | DKK 155.4m | DKK 176.7m |
| Total assets | DKK 286.9m | DKK 330.6m | DKK 348.6m |
| Cash | DKK 543k | DKK 1.1m | – |
| Short-term debt | DKK 203.8m | DKK 146.0m | – |
| Avg. employees | 60 | 64 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Den uafhængige revisors erklæring · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 198 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 96 | ||
| 1 Jan 2022 – 31 Dec 2022 | 150 | ||
| 1 Jan 2021 – 31 Dec 2021 | 154 | ||
| 1 Jan 2020 – 31 Dec 2020 | 60 | ||
| 1 Jan 2019 – 31 Dec 2019 | 69 | ||
| 1 Jan 2018 – 31 Dec 2018 | 129 | ||
| 1 Jan 2017 – 31 Dec 2017 | 144 | ||
| 1 Jan 2016 – 31 Dec 2016 | 94 | ||
| 1 Jan 2015 – 31 Dec 2015 | 151 | ||
| 1 Jan 2014 – 31 Dec 2014 | 149 | ||
| 1 Jan 2013 – 31 Dec 2013 | 130 | ||
| 1 Jan 2012 – 31 Dec 2012 | 160 | ||
| 1 Jan 2011 – 31 Dec 2011 | 172 | ||
| 1 Jan 2010 – 31 Dec 2010 | 101 | ||
| 1 Jan 2009 – 31 Dec 2009 | 89 | ||
| 1 Jan 2008 – 31 Dec 2008 | 97 | ||
| 1 Jan 2007 – 31 Dec 2007 | 141 | ||
| 1 Jan 2006 – 31 Dec 2006 | 77 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Hans Gunnar Larsen | ||
| CEO | Lars Skov Ibsen | ||
| CEO | Peder Ringgaard | ||
| CEO | Henrik Fuglsang | ||
| CEO | Morten Bergstrand | ||
| Board | Aaron Michael Wong | Current | |
| Board | Stig Løkke Pedersen | Current | |
| Board | Michael Frederik Ryde | Current | |
| Board | Flemming Jürgensen | ||
| Board | Hans Gunnar Larsen | ||
| Board | Svend Erik Beier | ||
| Board | Peder Ringgaard | ||
| Board | Lars Lagerstedt | ||
| Board | Håkan Englund | ||
| Board | Jan Ingvar Tommy Nilsson | ||
| Board | Karl Håkan Franzén | ||
| Board | Leif Jan Lennart Sellden | ||
| Board | Jorge Arnaldo Cerda Lucero | ||
| Board | Lars Lagerstedt | ||
| Board | Per Sundqvist | ||
| Board | Jens Karl Jensen | ||
| Board | Birgit Mindegaard | ||
| Board | Lars Skov Ibsen | ||
| Board | Theodor Skov | ||
| Board | Jan Vælds | ||
| Board | Hans Henrik Gunnar Lidgard | ||
| Board | Richardt Sonnichsen | ||
| Board | Thomas Lauridsen | ||
| Board | Lars Aaen | ||
| Board | Kim Frank Andersen | ||
| Board | Svend Aage Dreist Hansen | ||
| Board | Thomas Lauridsen | ||
| Board | Morten Bergstrand | ||
| Board | Rasmus Boas Thygesen | ||
| Board | Steen Asferg Rasmussen | ||
| Board | Jens-Christian Sander Olsen | ||
| Board | Morten Bergstrand | ||
| Board | Jens Winther Moberg | ||
| Board | Hans Henrik Gunnar Lidgard | ||
| Board | Justin Patrick Pierce | ||
| Board | Petra Jönsson Sjölin | ||
| Board | Fredrik Alvin Andersson | ||
| Owner (100%) | PK BIOTECH ApS | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | INTERREVISION A/S | ||
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | ALBERT PEDERSEN, STATSAUTORISEREDE REVISORER I/S | ||
| Auditor | ADDERE REVISION STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | BUUS JENSEN I/S STATSAUTORISEREDE REVISORER | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | ||
| Founder | Peter Ernst Wengler-Jørgensen | Current | |
| Founder | PHARMACIA SERVICE A/S | Current | |
| Founder | PROCORDIA ApS | Current |
The CEOs' other companies
Lars Skov Ibsen – 12 other companies, of which 4 bankrupt
- ApS af 25/1 2022 Bankrupt 9 Feb 2022
- KOMPLEMENTARSELSKABET SCANDINAVIAN PROPERTY INVESTMENT 10 ApS Bankrupt 4 Oct 2024
- OliveAll A/S Bankrupt 6 Jan 2020
- Vitaepet ApS Bankrupt 14 Nov 2022
- COMPLEMEDIC ApS Opløst
- GK PHARMA ApS Active
- OA2017 ApS Opløst
- PK BIOTECH ApS Active
- PK BIOTECH HOLDING ApS Compulsorily dissolved
- PK CHEMICALS HOLDING ApS Opløst
- PK SOLUTIONS A/S Compulsorily dissolved
- SPI ADMINISTRATION ApS Active
Peder Ringgaard – 2 other companies
- MCNEIL ESBJERG ApS Fusioneret
- PHARMACIA SERVICE A/S Fusioneret
Henrik Fuglsang – 4 other companies
- HEFU Consulting ApS Active
- HEFU Holding ApS Active
- PK BIOTECH ApS Active
- PKB INVEST ApS Fusioneret
Morten Bergstrand – 45 other companies, of which 5 bankrupt
- 1. juni 2015 ApS Bankrupt 12 Nov 2015
- FISKEHUSET ApS Bankrupt 18 May 2011
- FISKEHUSET ESPERGÆRDE HAVN ApS Bankrupt 3 Nov 2011
- HM VVS MONTAGE ApS Bankrupt 1 Dec 2015
- MMJ aps Bankrupt 6 Oct 2026
- BJERRE & CO TRADING ApS Compulsorily dissolved
- Brdr. Soland Ejendomme ApS Opløst
- Cykelbixen Køge ApS Opløst
- Cykelbixen Køge II ApS Opløst
- Den Gamle Smedje Ll. Skensved ApS Active
- EJENDOMSSELSKABET GLOSEMOSEVEJ ApS Opløst
- EJENDOMSSELSKABET LUNDTOFTEGAARD ApS Active
- EJENDOMSSELSKABET NØRRE BOULEVARD 53-57 ApS Fusioneret
- ESPERGÆRDE FISKEHUS ApS Active
- Ejendomsselskabet Foldagervej 6 ApS Active
- Ejendomsselskabet Højelsevej ApS Active
- Ejendomsselskabet Jonstrupvej 246 ApS Opløst
- Ejendomsselskabet Ringsted Mark ApS Active
- Ejendomsselskabet Stensbjergvej 1, Køge ApS Fusioneret
- Ejendomsselskabet Stensbjergvej 11, Køge A/S Fusioneret
- Ejendomsselskabet Stensbjergvej 7, Køge ApS Fusioneret
- Ejendomsselskabet Sundvej 6 ApS Active
- Ejendomsselskabet Sygehusvej ApS Active
- Ejendomsselskabet Vestergade 41 ApS Fusioneret
- HALLE & MORTENS EJENDOMSSELSKAB ApS Active
- HB KØGE A/S Active
- HM RUSTFRI DESIGN ApS Active
- Henriksen & Jørgensen Eftf. ApS Opløst
- JML Ejendomme Køge ApS Active
- KARINETTE ApS Fusioneret
Address history (0 moves)
| Københavnsvej 140, 4600 Køge |
Former names
| Magle Biopolymers A/S | – now |
| PK CHEMICALS A/S | – |
| PHARMACIA KØGE CHEMICALS A/S | – |
Employees per year
Other companies at the same address
- LM HOLDING KØGE ApS Opløst
- PK CHEMICALS HOLDING ApS Opløst
- PKB INVEST ApS Fusioneret
Questions and answers about Magle Biopolymers A/S
Has Magle Biopolymers A/S gone bankrupt?
No, Magle Biopolymers A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Magle Biopolymers A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of Magle Biopolymers A/S?
Magle Biopolymers A/S most recently used EY Godkendt Revisionspartnerselskab.
When was Magle Biopolymers A/S founded?
Magle Biopolymers A/S was founded on 21 February 1991.
What is the equity of Magle Biopolymers A/S?
Equity was DKK 83.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.